Medicare Enrolled
Dr. Kevin Berman, M.D, , PH.D.
Dermatology · Roswell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berman
Dr. Kevin Berman is a dermatology specialist in Roswell, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berman performed 11,440 Medicare services across 6,554 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berman received a total of $14,289 from 42 pharmaceutical and/or device companies across 722 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in GA
$14,289 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,440
Medicare services
Top 6% in GA for dermatology
6,554
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~572 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
4,105 | $5 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,251 | $60 | $181 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,749 | $35 | $174 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
1,133 | $71 | $219 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
289 | $69 | $234 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
285 | $81 | $295 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
202 | $136 | $472 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $91 | $260 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 177 | $143 | $494 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
164 | $136 | $381 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
157 | $127 | $463 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
124 | $86 | $313 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
115 | $38 | $110 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $38 | $112 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
87 | $211 | $628 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
83 | $56 | $264 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
70 | $63 | $396 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $114 | $352 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
28 | $36 | $148 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
24 | $102 | $379 |
| Skin cancer growth removal, 0.6-1.0 cm This procedure involves the surgical removal of a cancerous skin growth located on the body, arms, or legs. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
20 | $85 | $607 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
20 | $244 | $798 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
18 | $81 | $265 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,289
Total received (2018-2024)
Avg $2,041/year across 7 years
Top 11% in GA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
722
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,315 (93.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$974 (6.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,884
2023
$2,200
2022
$2,421
2021
$2,244
2020
$1,175
2019
$1,789
2018
$1,577
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$661
Regeneron Healthcare Solutions, Inc.
$379
GENZYME CORPORATION
$365
Janssen Biotech, Inc.
$332
LEO Pharma Inc.
$191
Lilly USA, LLC
$154
UCB, Inc.
$153
E.R. Squibb & Sons, L.L.C.
$147
Arcutis Biotherapeutics, Inc.
$83
Incyte Corporation
$75
Amgen Inc.
$74
Novartis Pharmaceuticals Corporation
$73
Dermavant Sciences, Inc.
$58
PFIZER INC.
$37
Verrica Pharmaceuticals Inc.
$32
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Galderma Laboratories, L.P.
$19
Ortho Dermatologics, a division of Bausch Health US, LLC
$18
Teva Pharmaceuticals USA, Inc.
$14
Top 3 companies account for 48.7% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$1,357
ABBVIE INC.
$1,354
GENZYME CORPORATION
$1,250
AbbVie Inc.
$1,134
LEO Pharma Inc.
$1,035
Lilly USA, LLC
$1,023
Janssen Biotech, Inc.
$856
Novartis Pharmaceuticals Corporation
$833
UCB, Inc.
$666
Encore Dermatology Inc.
$661
Amgen Inc.
$562
Ortho Dermatologics, a division of Bausch Health US, LLC
$464
PFIZER INC.
$444
Journey Medical Corporation
$358
AbbVie, Inc.
$357
E.R. Squibb & Sons, L.L.C.
$259
Galderma Laboratories, L.P.
$234
Celgene Corporation
$224
Sun Pharmaceutical Industries Inc.
$200
Almirall LLC
$195
Dermavant Sciences, Inc.
$136
Arcutis Biotherapeutics, Inc.
$125
Incyte Corporation
$102
Mayne Pharma Inc.
$66
SUN PHARMACEUTICAL INDUSTRIES INC.
$55
MAYNE PHARMA COMMERCIAL LLC
$47
VYNE Pharmaceuticals Inc.
$36
EPI Health, LLC
$36
Verrica Pharmaceuticals Inc.
$32
Merck Sharp & Dohme Corporation
$26
DERMIRA, INC.
$23
Mylan Pharmaceuticals Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Novum Pharma, LLC
$16
Teva Pharmaceuticals USA, Inc.
$14
MAYNE PHARMA INC.
$14
Promius Pharma LLC
$13
Medtronic, Inc.
$13
Biofrontera Inc.
$13
STRATA Skin Sciences, Inc.
$12
Glenmark Therapeutics Inc.
$4
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$3
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Aczone · Alcortin A · Bimzelx · CIBINQO · CLODERM · COSENTYX · Ceracade · Cimzia · DALVANCE · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Exelderm · FINACEA · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · LIBTAYO · LifeVest · Mupirocin Cream · OPZELURA · ORACEA · Olux · Otezla · QBREXZA · REMICADE · RINVOQ · SILIQ · SIMLANDI · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRIANEX 0.05% · TargaDox · Tremfya · VENASEAL · VTAMA · Winlevi · XIMINO (minocycline hydrochloride) extended-release capsules · XTRAC · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
185
Per 100K population
17.3
County median income
$91,490
Nearest hospital
WELLSTAR NORTH FULTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Berman is a clinical cardiology specialist, with above-average Medicare volume (top 6% in GA), with low-engagement industry engagement in the top 11% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Berman experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Berman performed 4,105 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berman receive payments from pharmaceutical companies?
Yes. Dr. Berman received a total of $14,289 from 42 companies across 722 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berman's costs compare to other dermatologists in Roswell?
Dr. Berman's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Roswell
Browse dermatologists in Roswell ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in GA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in GA
Which GA dermatologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology